Click on the "Follow" button below and you'll get the latest news from British Journal of General Practice via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
British Journal of General Practice title: British Journal of General Practice |
Is this your feed? Claim it!
It is perplexing to read this Tookman et al article Dec 2025.1 Many people find themselves suffering persistent ‘unexplained’ physical symptoms downstream of taking very common medicines – as prescribed – for anxiety, depression, stress and other indications.
‘The problem’ identified by Tookman et al1 is that “P...
We were very pleased to read the thoughtful response by Kane and colleagues to our qualitative interview study on barriers that deter GPs from discussing sexual assault with patients. Their findings provide important complementary evidence and reinforce the need for educational interventions that support primary care professionals in ad...
Alistair Hay describes his vision as one which would have enthused him as a newly qualified GP. I'm afraid I must disagree - he has sketched out what seems to me to be a vision of hell. I trained as a GP in order to care for the whole person; what Hay is suggesting here is a fragmented and taskified model, where each episode of illness i...
The article on missingness1 is timely in well emphasising the importance of missingness. The authors rightfully referred to the inspiring achievement of Tudor Hart (1975)2 who measured the blood pressure of every one of his patients. He did this because he had a personal list and knew his patients personally. That work is a textbook exam...
Heaney and colleagues make a persuasive case that the 2024 UK asthma guidelines should move asthma care beyond symptoms alone, particularly for patients who remain uncontrolled despite MART ¹. This is an important shift. However, I think the understandable enthusiasm for T2 biomarkers should not overshadow the more ordinary medicines-use...